Innate Pharma (IPHA) Debt to Equity (2017 - 2025)
Innate Pharma (IPHA) reported Debt to Equity of -$1.04 for Q4 2025, down 129.64% on a YoY basis from $3.51 in Q4 2024, and down 119.79% quarter-over-quarter from $5.25 in Q2 2025.
Innate Pharma (IPHA) Debt to Equity (2017 - 2025) Analysis & Trends
Innate Pharma has reported Debt to Equity for 9 years, with the latest figure at -$1.04 in Q4 2025.
- For the quarter ending Q4 2025, Debt to Equity fell 129.64% year-over-year to -$1.04; the trailing twelve-month figure through Dec 2025 stood at -$1.04 (down 129.64% YoY), and the FY2025 full-year result was -$1.04, down 129.64% from the prior year.
- Debt to Equity for Q4 2025 stood at -$1.04, down from $5.25 in the prior quarter.
- The five-year high for Debt to Equity was $5.25 in Q2 2025, with the low at -$1.04 in Q4 2025.
- Historically, Debt to Equity has averaged $1.21 across 5 years, with a median of $0.74 in 2023.
- Annual changes were most pronounced in 2024 — Debt to Equity surged 356.47% — and 2025, when it plunged 129.64%.
- Innate Pharma's Debt to Equity stood at $0.41 in 2021, then jumped by 89.44% to $0.78 in 2022, then slipped by 1.49% to $0.77 in 2023, then soared by 356.47% to $3.51 in 2024, then sank by 129.64% to -$1.04 in 2025.
- The last three Debt to Equity figures came in at -$1.04 (Q4 2025), $5.25 (Q2 2025), and $3.51 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Innate Pharma | 194.19 Mn | 194.19 Mn | - | -1.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.04 |
| Jun 30, 2025 | 5.25 |
| Dec 31, 2024 | 3.51 |
| Jun 30, 2024 | 1.23 |
| Dec 31, 2023 | 0.77 |
| Jun 30, 2023 | 0.70 |
| Dec 31, 2022 | 0.78 |
| Jun 30, 2022 | 0.37 |
| Dec 31, 2021 | 0.41 |
| Jun 30, 2021 | 0.12 |
| Dec 31, 2020 | 0.12 |
| Jun 30, 2020 | 0.09 |
| Dec 31, 2019 | 0.09 |
| Dec 31, 2018 | 0.03 |
| Dec 31, 2017 | 0.07 |